BMY vs. VTI

In the year-to-date period, BMY achieves a -15.07% return, which is significantly lower than VTI's -0.70% return. Over the past 10 years, BMY has underperformed VTI with an annualized return of -0.53%, while VTI has yielded a comparatively higher 11.92% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and Vanguard Total Stock Market ETF (VTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BMY Sharpe Ratio is 0.53, which is comparable to the VTI Sharpe Ratio of 0.52. The chart below compares the historical Sharpe Ratios of BMY and VTI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BMY's dividend yield for the trailing twelve months is around 5.19%, more than VTI's 1.31% yield.

The maximum BMY drawdown since its inception was -70.62%, which is greater than VTI's maximum drawdown of -55.45%. Use the drawdown chart below to compare losses from any high point for BMY and VTI. For additional features, visit the drawdowns tool.

Bristol-Myers Squibb Company (BMY) has a higher volatility of 11.68% compared to Vanguard Total Stock Market ETF (VTI) at 4.88%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than VTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.